NCT06093594View on ClinicalTrials.gov

Investigating Participation Patterns Among Stage IV Melanoma Patients

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2026

Conditions
Stage IV Melanoma
Trial Locations (1)

94107

Power Life Sciences, San Francisco

Sponsors
All Listed Sponsors
lead

Power Life Sciences Inc.

INDUSTRY

NCT06093594 - Investigating Participation Patterns Among Stage IV Melanoma Patients | Biotech Hunter | Biotech Hunter